Atricure, Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atricure with three other
companies in this sector in UNITED STATES :
sales of $270.63 million
of which 44%
was Vascular Interventions & Therapies),
Cardiovascular Systems, Incorporation
of which 72%
was Peripheral Products), and
Tactile Systems Technology Inc
Atricure reported sales of $230.81 million
December of 2019.
increase of 14.5%
versus 2018, when the company's sales were $201.63 million.
Sales at Atricure have increased during each of the previous five years
(and since 2014, sales have increased a total of 115%).
Sales of Valve Tools -United States saw an increase
that was more than double the company's growth rate: sales were up
34.0% in 2019, from
$1.95 million to $2.62 million.
Atricure also saw significant increases in sales in
Appendage Management-United States (up 28.9% to $68.17 million)
Not all segments of Atricure experienced an increase in sales in 2019:
sales of Minimally Invasive Ablation-United State fell 0.6% to $34.84 million.